TRICALS for ALS Patients

TRICALS aims to speed up the development of new medicines for ALS. You can help by registering with TRICALS. 

The participation of ALS patients in clinical trials is necessary to find better treatments.

After registration, we will inform you about upcoming trials and about results of completed trials. After your permission, we will inform you on trials that are recruiting patients and you will be invited to an ALS centre that you chose, for further counselling and screening.

We are currently experiencing some trouble with registrations, and are working hard to solve this. We kindly request you not to use the ‘Register now’ button, but to please e-mail us at if you would like to receive updates on TRICALS. Our apologies for the inconvenience.

Register now

What are clinical trials?

Clinical trials are research studies that test how well new medical approaches work in people with ALS. Each study answers scienti c questions and tries to nd better ways to screen for, diagnose, or treat ALS. Every clinical trial has a protocol (an action plan), for conducting the trial. This plan describes what will be done in the study, how it will be conducted, and why each part of the study is necessary. Each study has its own rules about who can take part. In every country, an independent committee of physicians, statisticians, and members of the community must approve and monitor the protocol. They make sure that the potential bene ts are worth the risks, and that these risks are limited.

Trial overview